BTG ups revenue estimates
BTG, the specialist healthcare company, has upped its full year revenue guidance after a strong showing at its licensing & biotechnology business.
BTG, the specialist healthcare company, has upped its full year revenue guidance after a strong showing at its licensing & biotechnology business.
The firm is raising its revenue estimate for the year ended 31 March 2012 from a forecast of £160m-£165m to £190m-£195m.
The new figure reflects revised expectations of around £29m in royalties on inventories of blood clotting drug BeneFIX, following patent expiry in March 2011.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
The company also saw a strong performance from its prostate cancer treatment Zytiga,
Trading at BTC's specialty pharmaceuticals and interventional medicine business divisions had been in line with expectations, it added.
Chief Executive Louise Maki said the company had delivered a strong financial and operating performance across the business.
"Our development programmes are on track and we have made good progress in our interventional medicine business," she added.
Sign up for MoneyWeek's newsletters
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
-
8 of the best houses for sale for around £1 million
This week: the best houses for sale for around £1 million – from a wing of a Grade II-listed Victorian manor house in Sunderland, to a brick-and-flint cottage in Cley next the Sea, Norfolk
By Natasha Langan Published
-
Starling Bank to scrap 3.25% interest rate from popular current account within days
Starling is to remove the generous 3.25% it pays on current accounts from next week – what does this mean for customers and should you move?
By Katie Williams Published